Research on host-pathogen interaction, and disease genetics focusing One Health Approach.
Infectious Diseases caused by pathogens account for considerable morbidity and mortality worldwide. The highest mortality among infectious diseases comes from lower respiratory tract infections followed by enteric infections, AIDS, and malaria. Additionally, several other neglected diseases can be transmitted between animal and human hosts and had received low profile status in public health priorities through half of the world’s population is at the risk of contracting these diseases. Realizing the significance of neglected diseases on the economic burden, policymakers and funding agencies have begun to increase their support in recent years for research and effective integrated programs for the control of neglected diseases.
Area of Interest
- Broad-spectrum antivirals for respiratory virus.
- Evaluate Biomarkers for the early prediction of viral disease outcome.
- Virus and host genetic variability and their potential impact on immunogen response and efficacy (Viral diseases like Dengue, SARS-CoV, HIV, etc).
- New and repurposing of drugs for viral and neglected tropical parasitic diseases.
- Improved treatment modalities for TB and HIV co-infection.
- Antiviral, antibacterial and ant parasitic resistance.
- Non-invasive biomarkers for clinical diagnosis of enteric pathogens.
- Environmental enteric dysfunction (EED).
- We use our organic association with the medical colleges of SBV and other regional institutions to capture a fairly large population landscape who come for treatment.
- We primarily focus on local and regional infectious disease priorities.
- Fair use of novel tools and technologies available in-house and outsourced basis.
- We assess the Epidemiological, social impacts of vaccines and preventive interventions for respiratory viral, vector borne viral and neglected tropical diseases (including alternative medicines as prophylaxis).